Clinical Trials in Chicago

Showing 6781-6800 of 15,574 trials

A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2)

NCT04897412

The Stage 2 of this phase 2 study will be a randomized, single-blind, placebo-controlled, parallel, and multiple-dose study to assess the efficacy, safety, and subject satisfaction of CBL-514.

Subcutaneous Fat

Caliway Biopharmaceuticals Co., Ltd.75 participantsStarted Feb 2022

Chicago, Illinois, United States • Omaha, Nebraska, United States • Nashville, Tennessee, United States +2 more locations

COMPLETEDPhase 32.2 miles

Randomized Trial in Adult Participants With Acute Migraines

NCT04571060

The purpose of this study is to test the safety and efficacy of BHV-3500 (zavegepant) versus placebo in the acute treatment of moderate or severe migraine.

Migraine

Pfizer1,978 participantsStarted Oct 2020

Huntsville, Alabama, United States • Mobile, Alabama, United States • Chandler, Arizona, United States +91 more locations

A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2)

Randomized Trial in Adult Participants With Acute Migraines

Find Trials by Condition in Chicago

PHAT Life: Peer Versus Adult-Led HIV Prevention for Juvenile Offenders

Effects of GLYX-13 on Learning and Memory in Healthy Individuals and Those With Psychiatric Illness

Genomic Response Analysis of Heart Failure Therapy in African Americans

A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer

Effectiveness Trial of an E-Health Intervention To Support Diabetes Care in Minority Youth (3Ms)

A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)

Bispectral Index and End-Tidal Anesthetic Gas Concentration in Pediatric Patients

tPA by Endovascular Administration for the Treatment of Submassive PE Using CDT for the Reduction of Thrombus Burden

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Docetaxel for Metastatic Non-Small Cell Lung Cancer (NSCLC) (PRESERVE 4)

The SUN Clinical Trial (Safety Utilizing NUsurface Meniscus Implant)

Study to Identify and Determine Best Implementation Practices for Injectable Cabotegravir+Rilpivirine in the United States (US)

A Study to Evaluate the Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis

Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures

A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia

VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study

Rapid Diagnostics for HIV and Hepatitis

Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults

Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)